Barry J. Simon
CIK 1647994 · See remarks · last filed 2026-06-05
Barry J. Simon is a corporate insider who has filed 36 SEC Form 4 insider transactions across 4 companies since 2015. The most recent filing shows the insider sold $165.3K of IBRX on Jun 5, 2026. Across all open-market trades the lifetime net is −$17.3M, making them a net seller over the disclosed history. Current disclosed insider exposure totals $20.1M across reported positions.
"Disclosed insider exposure" sums this person's most-recently-reported share counts across each company they're an insider in, multiplied by the current underlying price. It is not net worth — it misses retail holdings, private investments, real estate, index funds, and any company where the person isn't an SEC-reporting insider. For informational purposes only.
$20.08M
4
36
-$17.32M
Holdings By Company
| Symbol | Role | Shares | Price | Disclosed Exposure | Lifetime OM Net | Filings | Latest Filed |
|---|---|---|---|---|---|---|---|
| IBRX | Director | 2,827,788 | $7.10 | $20.08M | -$5.96M | 13 | 2026-06-05 |
| Viracta Therapeutics, Inc. (VIRX) Delisted | Director | — | $0.01 | — | $0 | 4 | 2024-06-24 |
| ImmunityBio, Inc. (NK) Delisted | See remarks | 3,213,783 | — | — | -$11.36M | 15 | 2021-02-08 |
| CUE | Director | — | $24.53 | — | $0 | 4 | 2021-01-06 |
Recent Filings
36 filings| Filed | Symbol | Action | Net Shares | Net $ | Link |
|---|---|---|---|---|---|
| 2026-06-05 | IBRX | Sell (S) | −23,033 | -$165.3K | EDGAR |
| 2026-02-26 | IBRX | Sell (S) | −75,000 | -$900.8K | EDGAR |
| 2026-02-24 | IBRX | Mixed | −165,783 | -$1.84M | EDGAR |
| 2026-01-21 | IBRX | Sell (S) | −151,967 | -$1.09M | EDGAR |
| 2025-02-25 | IBRX | Mixed | +9,790 | -$18.6K | EDGAR |
| 2025-01-24 | IBRX | Exer (M) | +110,020 | $219.9K | EDGAR |
| 2024-06-24 | Viracta Therapeutics, Inc. (VIRX) Delisted | Grant (A) | — | $0 | EDGAR |
| 2024-02-26 | IBRX | Grant (A) | — | $0 | EDGAR |
| 2024-02-02 | IBRX | Mixed | +35,106 | -$74.2K | EDGAR |
| 2023-09-06 | IBRX | Exer (M) | +57,199 | $0 | EDGAR |